First-generation antihistamine + 5-HT₂A antagonist
Cyproheptadine hydrochloride
Brand names: Periactin
Adult dose
Dose: 4mg TDS (max 32mg/day); serotonin syndrome (off-label): 12mg loading then 2mg q2h
Route: Oral
Frequency: TDS
Clinical pearls
- TOXBASE: option for moderate–severe serotonin syndrome alongside supportive care
- Off-label appetite stimulant in cachexia, periodic migraine prophylaxis (paediatrics)
- Pre-second-generation antihistamine; daytime sedation limits use
Contraindications
- Closed-angle glaucoma
- Pyloric stenosis
- Bladder neck obstruction
- Concurrent MAOI
- Elderly debilitated patients
- Hypersensitivity
Side effects
- Sedation
- Anticholinergic effects
- Weight gain (appetite stimulation)
- Dry mouth
- Urinary retention
Interactions
- MAOIs
- Other anticholinergics
- Alcohol
Monitoring
- Sedation
- Weight
- Anticholinergic burden
Reference: BNF; TOXBASE / NPIS serotonin syndrome; SmPC; https://bnf.nice.org.uk/drugs/cyproheptadine-hydrochloride/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023